Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer.
AUSTIN, Texas, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused...
AUSTIN, Texas, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM” or the “Company”), a clinical-stage biopharmaceutical company focused...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.1072 | 0.1072 | 0.1072 | 0 | 0 | CS |
4 | -0.3427 | -76.1724827739 | 0.4499 | 0.4499 | 0.1 | 1246552 | 0.21364328 | CS |
12 | -0.2148 | -66.7080745342 | 0.322 | 1.34 | 0.1 | 16214692 | 0.63937525 | CS |
26 | -1.0828 | -90.9915966387 | 1.19 | 1.59 | 0.1 | 7372898 | 0.63858709 | CS |
52 | -3.3328 | -96.8837209302 | 3.44 | 4.12 | 0.1 | 3800349 | 0.6466361 | CS |
156 | -57.7928 | -99.8148531952 | 57.9 | 63.6 | 0.1 | 1423144 | 2.01691816 | CS |
260 | -202.3928 | -99.9470617284 | 202.5 | 286.8435 | 0.1 | 988173 | 24.0913079 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales